drugset / Trial / NCT03906565
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Phase 2
Suspended
30 enrolled
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals · collab
NaSingle-groupOpen-labelTreatment
Summary
To assess the effectiveness and safety of utidelone injection in patients with advanced or metastatic colorectal cancer (CRC) as a phase II trial
Timeline
- Start
- 2019-04-12
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Outcome
Outcome not reported
Stopped: “The efficacy evaluation (based on current data) deviated too much from results of previous clinical trials. It's assumed that high dropout rate of subjects, mainly due to covid-19 epidemic in China in the past 3 years, is the main reason.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epothilone D | Small molecule | 40 mg/m2 | Intravenous |